Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
09/07/202406:11Alliance NewsAlliance NewsIN BRIEF: Regeneron says second quarter results to include R&D chargeLSE:0R2MRegeneron Pharmaceuticals Inc
09/07/202406:09PR Newswire (US)Soul App's Three New Features Unveiled at WAIC, Epitomizing the Product Philosophy of "Synergic Model-application Interplay"
09/07/202406:05PR Newswire (US)Altair Named Samsung Advanced Foundry Ecosystem PartnerNASDAQ:ALTRAltair Engineering Inc
09/07/202406:05PR Newswire (US)Altair Named Samsung Advanced Foundry Ecosystem PartnerNASDAQ:ALTRAltair Engineering Inc
09/07/202406:00UK RegulatoryAmundi et Victory Capital signent un accord définitif pour devenir des partenaires stratégiquesEU:AMUNAmundi
09/07/202406:00UK RegulatoryAmundi and Victory Capital sign a definitive agreement to become strategic partnersEU:AMUNAmundi
09/07/202406:00UK RegulatoryAmundi and Victory Capital sign a definitive agreement to become strategic partnersTG:ANIAmundi
09/07/202406:00UK RegulatoryAmundi et Victory Capital signent un accord définitif pour devenir des partenaires stratégiquesTG:ANIAmundi
09/07/202406:00UK RegulatoryVivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney DiseaseTG:05YVivoryon Therapeut
09/07/202406:00UK RegulatoryVivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney DiseaseEU:VVYVivoryon Therapeut
09/07/202406:00UK RegulatoryAS Tallinna Sadam operational volumes for 2024 Q2 and 6 months
09/07/202406:00UK RegulatoryRoche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetesLSE:0QQ6Roche Holding Ag
09/07/202406:00UK RegulatoryVivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney DiseaseLSE:0R3MVivoryon Therapeutics Nv
09/07/202406:00UK RegulatoryStart of Day Message
09/07/202406:00PR Newswire (US)DataShapes AI to Participate in Cyber Quest 2024
09/07/202406:00UK RegulatoryPR Newswire - Start of Day
09/07/202405:58Alliance NewsAlliance NewsTOP NEWS: Cooler weather pegs back UK retail sales in June
09/07/202405:44Alliance NewsAlliance NewsGLOBAL BRIEFING: Stocks mixed but dollar firms, Biden doubles down
09/07/202405:39PR Newswire (US)NeuroX Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
09/07/202405:01PR Newswire (US)Can M&A Bounce Back in 2024? Second Half of 2024 Points to a Mixed Recovery for M&A
09/07/202405:01PR Newswire (US)Boston Consulting Group Joins Greentown Labs as a Terawatt Partner
09/07/202405:01PR Newswire (US)Interius BioTherapeutics Receives HREC Approval and CTN Clearance from the TGA to Commence a Phase 1 Clinical Trial for Its First-in-Class In Vivo CAR Therapeutic for B Cell Malignancies
09/07/202405:00PR Newswire (US)Summer becomes a thrilling adventure for a teenage boy after planting an unusual rock in his backyard that grows into a towering mountain
09/07/202405:00PR Newswire (US)THINKFREE Launches Beta Version of Global Corporate AI Search Service Refinder AI
09/07/202405:00PR Newswire (US)Peter Durbin explores the mysteries of the End Times and beyond in 'What`s Really Going On?'
09/07/202405:00PR Newswire (US)THINKFREE Launches Beta Version of Global Corporate AI Search Service Refinder AI
09/07/202405:00PR Newswire (US)Universal Robots celebrates milestone with over 500 innovative products in its ever-expanding ecosystem
09/07/202405:00PR Newswire (US)Fluree Named a 2024 Gartner Cool Vendor in Data Management
09/07/202403:56PR Newswire (US)STEM Director Named America's Favorite Teacher 2024: Colossal Raises Over $2.7 Million Benefiting Teach For America
09/07/202403:54PR Newswire (US)UNLIMEAT Introduces Its K-Vegan Products at Sprouts Farmers Market